Fusarium infections in immunocompromised patients

Clinical Microbiology Reviews

Volumn 20, Issue 4, 2007, Pages 695-704

  Nucci, Marcio ^a   Anaissie, Elias ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ITRACONAZOLE; POSACONAZOLE; TERBINAFINE; VORICONAZOLE;

CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; ENDOPHTHALMITIS; FUNGEMIA; FUSARIUM; HOST RESISTANCE; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION PREVENTION; MYCOSIS; NONHUMAN; PATHOGENESIS; PNEUMONIA; PROGNOSIS; REVIEW; SINUSITIS; SKIN DISEASE;

ANIMALS; ANTIFUNGAL AGENTS; FUSARIUM; HUMANS; IMMUNOCOMPROMISED HOST; MICE; MICROBIAL SENSITIVITY TESTS; MYCOSES;

FUSARIUM;

EID: 35448960891     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.00014-07     Document Type: Review

References (113)

1. Ammari, L. K., J. M. Puck, and K. L. McGowan. 1993. Catheter-related Fusarium solani fungemia and pulmonary infection in a patient with leukemia in remission. Clin. Infect. Dis. 16:148-150.
2. Anaissie, E. J., R. T. Kuchar, J. H. Rex, A. Francesconi, M. Kasai, F. M. Muller, M. Lozano-Chiu, R. C. Summerbell, M. C. Dignani, S. J. Chanock, and T. J. Walsh. 2001. Fusariosis associated with pathogenic Fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections. Clin. Infect. Dis. 33:1871-1878.
3. Anaissie, E. J., S. L. Stratton, M. C. Dignani, C. K. Lee, T. H. Mahfouz, J. H. Rex, R. C. Summerbell, and T. J. Walsh. 2002. Cleaning patient shower facilities: a novel approach to reducing patient exposure to aerosolized Aspergillus species and other opportunistic molds. Clin. Infect. Dis. 35:E86-E88.
4. Anandi, V., P. Vishwanathan, S. Sasikala, M. Rangarajan, C. S. Subramaniyan, and N. Chidambaram. 2005. Fusarium solani breast abscess. Indian J. Med. Microbiol. 23:198-199.
5. Apostolidis, J., M. Bouzani, E. Platsouka, H. Belasiotou, M. Stamouli, N. Harhalakis, E. I. Boutati, O. Paniara, and E. Nikiforakis. 2003. Resolution of fungemia due to Fusarium species in a patient with acute leukemia treated with caspofungin. Clin. Infect. Dis. 36:1349-1350.
6. Arikan, S., M. Lozano-Chiu, V. Paetznick, S. Nangia, and J. H. Rex. 1999. Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species. J. Clin. Microbiol. 37:3946-3951.
7. Bader, M., A. K. Jafri, T. Krueger, and V. Kumar. 2003. Fusarium osteomyelitis of the foot in a patient with diabetes mellitus. Scand. J. Infect. Dis. 35:895-896.
8. Baldwin, J. E., and E. P. Wraight. 1990. Indium labelled leucocyte scintigraphy in occult infection: a comparison with ultrasound and computed tomography. Clin. Radiol. 42:199-202.
9. Bigley, V. H., R. F. Duarte, R. D. Gosling, C. C. Kibbler, S. Seaton, and M. Potter. 2004. Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole. Bone Marrow Transplant. 34:815-817.
10. Bourguignon, R. L., A. F. Walsh, J. C. Flynn, C. Baro, and E. Spinos. 1976. Fusarium species osteomyelitis. Case report. J. Bone Joint Surg. Am. 58: 722-723.
11. Boutati, E. I., and E. J. Anaissie. 1997. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood 90:999-1008.
12. Brilhante, R. S., R. A. Cordeiro, D. J. Medrano, M. F. Rocha, A. J. Monteiro, C. S. Cavalcante, T. E. Meireles, and J. J. Sidrim. 2005. Onychomycosis in Ceara (Northeast Brazil): epidemiological and laboratory aspects. Mem. Inst. Oswaldo Cruz 100:131-135.
13. Bunya, V. Y., K. M. Hammersmith, C. J. Rapuano, B. D. Ayres, and E. J. Cohen. 2007. Topical and oral voriconazole in the treatment of fungal keratitis. Am. J. Ophthalmol. 143:151-153.
14. Burgess, L. W. 1981. General ecology of the fusaria, p. 225-235. In P. E. Nelson, T. A. Toussoun, and R. J. Cook (ed.), Fusarium: diseases, biology, and taxonomy. Pennsylvania State University Press, Philadelphia, PA.
15. Castagnola, E., A. Garaventa, M. Conte, A. Barretta, E. Faggi, and C. Viscoli. 1993. Survival after fungemia due to Fusarium moniliforme in a child with neuroblastoma. Eur. J. Clin. Microbiol. Infect. Dis. 12:308-309.
16. Centers for Disease Control and Prevention. 2006. Update: Fusarium keratitis - United States, 2005-2006. Morb. Mortal. Wkly. Rep. 55:563-564.
17. Chang, D. C., G. B. Grant, K. O'Donnell, K. A. Wannemuehler, J. Noble-Wang, C. Y. Rao, L. M. Jacobson, C. S. Crowell, R. S. Sneed, F. M. Lewis, J. K. Schaffzin, M. A. Kainer, C. A. Genese, E. C. Alfonso, D. B. Jones, A. Srinivasan, S. K. Fridkin, and B. J. Park. 2006. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA 296:953-963.
18. Cocuroccia, B., J. Gaido, E. Gubinelli, G. Annessi, and G. Girolomoni. 2003. Localized cutaneous hyalohyphomycosis caused by a Fusarium species infection in a renal transplant patient. J. Clin. Microbiol. 41:905-907.
19. Consigny, S., N. Dhedin, A. Datry, S. Choquet, V. Leblond, and O. Chosidow. 2003. Successsful voriconazole treatment of disseminated Fusarium infection in an immunocompromised patient. Clin. Infect. Dis. 37:311-313.
20. Cuenca-Estrella, M., A. Gomez-Lopez, E. Mellado, M. J. Buitrago, A. Monzon, and J. L. Rodriguez-Tudela. 2006. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob. Agents Chemother. 50:917-921.
21. Cuenca-Estrella, M., A. Gomez-Lopez, E. Mellado, G. Garcia-Effron, A. Monzon, and J. L. Rodriguez-Tudela. 2005. In vitro activity of ravuconazole against 923 clinical isolates of nondermatophyte filamentous fungi. Antimicrob. Agents Chemother. 49:5136-5138.
22. Dignani, M. C., E. J. Anaissie, J. P. Hester, S. O'Brien, S. E. Vartivarian, J. H. Rex, H. Kantarjian, D. B. Jendiroba, B. Lichtiger, B. S. Andersson, and E. J. Freireich. 1997. Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study. Leukemia 11:1621-1630.
23. Doczi, I., T. Gyetvai, L. Kredics, and E. Nagy. 2004. Involvement of Fusarium spp. in fungal keratitis. Clin. Microbiol. Infect. 10:773-776.
24. Dornbusch, H. J., W. Buzina, R. C. Summerbell, C. Lass-Florl, H. Lackner, W. Schwinger, P. Sovinz, and C. Urban. 2005. Fusarium verticillioides abscess of the nasal septum in an immunosuppressed child: case report and identification of the morphologically atypical fungal strain. J. Clin. Microbiol. 43:1998-2001.
25. Durand-Joly, I., S. Alfandari, Z. Benchikh, M. Rodrigue, A. Espinel-Ingroff, B. Catteau, C. Cordevant, D. Camus, E. Dei-Cas, F. Bauters, L. Delhaes, and B. S. De. 2003. Successful outcome of disseminated Fusarium infection with skin localization treated with voriconazole and amphotericin B-lipid complex in a patient with acute leukemia. J. Clin. Microbiol. 41:4898-4900.
26. Dursun, D., V. Fernandez, D. Miller, and E. C. Alfonso. 2003. Advanced Fusarium keratitis progressing to endophthalmitis. Cornea 22:300-303.
27. Eljaschewitsch, J., J. Sandfort, K. Tintelnot, I. Horbach, and B. Ruf. 1996. Port-a-cath-related Fusarium oxysporum infection in an HIV-infected patient: treatment with liposomal amphotericin B. Mycoses 39:115-119.
28. Elvers, K. T., K. Leeming, C. P. Moore, and H. M. Lappin-Scott. 1998. Bacterial-fungal biofilms in flowing water photo-processing tanks. J. Appl. Microbiol. 84:607-618.
29. Espinel-Ingroff, A. 2003. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Rev. Iberoam. Micol. 20:121-136.
30. Espinel-Ingroff, A. 2001. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi. J. Clin. Microbiol. 39:1360-1367.
31. Espinel-Ingroff, A., V. Chaturvedi, A. Fothergill, and M. G. Rinaldi. 2002. Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study. J. Clin. Microbiol. 40:3776-3781.
32. Evans, J., D. Levesque, L. A. de, and H. E. Jensen. 2004. Intracranial fusariosis: a novel cause of fungal meningoencephalitis in a dog. Vet. Pathol. 41:510-514.
33. Ferrer, C., J. Alio, A. Rodriguez, M. Andreu, and F. Colom. 2005. Endophthalmitis caused by Fusarium proliferatum. J. Clin. Microbiol. 43:5372-5375.
34. Flynn, J. T., D. Meislich, B. A. Kaiser, M. S. Polinsky, and H. J. Baluarte. 1996. Fusarium peritonitis in a child on peritoneal dialysis: case report and review of the literature. Perit. Dial. Int. 16:52-57.
35. Gabriele, P., and R. K. Hutchins. 1996. Fusarium endophthalmitis in an intravenous drug abuser. Am. J. Ophthalmol. 122:119-121.
36. Garbino, J., I. Uckay, P. Rohner, D. Lew, and D. C. Van. 2005. Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature. Transpl. Int. 18:613-618.
37. Gardner, J. M., M. M. Nelson, and M. P. Heffernan. 2005. Chronic cutaneous fusariosis. Arch. Dermatol. 141:794-795.
38. Gaviria, J. M., J. A. van Burik, D. C. Dale, R. K. Root, and W. C. Liles. 1999. Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens. J. Infect. Dis. 179:1038-1041.
39. Godoy, P., E. Nunes, V. Silva, J. Tomimori-Yamashita, L. Zaror, and O. Fischman. 2004. Onychomycosis caused by Fusarium solani and Fusarium oxysporum in Sao Paulo, Brazil. Mycopathologia 157:287-290.
40. Grigis, A., C. Farina, F. Symoens, N. Nolard, and A. Goglio. 2000. Nosocomial pseudo-outbreak of Fusarium verticillioides associated with sterile plastic containers. Infect. Control Hosp. Epidemiol. 21:50-52.
41. Guimera-Martin-Neda, F., M. Garcia-Bustinduy, A. Noda-Cabrera, R. Sanchez-Gonzalez, and R. G. Montelongo. 2004. Cutaneous infection by Fusarium: successful treatment with oral voriconazole. Br. J. Dermatol. 150:777-778.
42. Guzman-Cottrill, J. A., X. Zheng, and E. G. Chadwick. 2004. Fusarium solani endocarditis successfully treated with liposomal amphotericin B and voriconazole. Pediatr. Infect. Dis. J. 23:1059-1061.
43. Hamaki, T., M. Kami, A. Kishi, E. Kusumi, Y. Kishi, H. Iwata, S. Miyakoshi, J. Ueyama, S. Morinaga, S. Taniguchi, K. Ohara, and Y. Muto. 2004. Vesicles as initial skin manifestation of disseminated fusariosis after non-myeloablative stem cell transplantation. Leuk. Lymphoma 45:631-633.
44. Hayden, R. T., P. A. Isotalo, T. Parrett, D. M. Wolk, X. Qian, G. D. Roberts, and R. V. Lloyd. 2003. In situ hybridization for the differentiation of Aspergillus, Fusarium, and Pseudallescheria species in tissue section. Diagn. Mol. Pathol. 12:21-26.
45. Healy, M., K. Reece, D. Walton, J. Huong, S. Frye, I. I. Raad, and D. P. Kontoyiannis. 2005. Use of the Diversi Lab System for species and strain differentiation of Fusarium species isolates. J. Clin. Microbiol. 43:5278-5280.
46. Hennequin, C., M. Benkerrou, J. L. Gaillard, S. Blanche, and S. Fraitag. 1994. Role of granulocyte colony-stimulating factor in the management of infection with Fusarium oxysporum in a neutropenic child. Clin. Infect. Dis. 18:490-491.
47. Hennequin, C., C. Ranaivoarimalala, T. Chouaki, M. Tazerout, T. Ancelle, J. J. Cabaud, and C. P. Raccurt. 2002. Comparison of aerobic standard medium with specific fungal medium for detecting Fusarium spp in blood cultures. Eur. J. Clin. Microbiol. Infect. Dis. 21:748-750.
48. Herbrecht, R., R. Kessler, C. Kravanja, M. H. Meyer, J. Waller, and V. Letscher-Bru. 2004. Successful treatment of Fusarium proliferatum pneumonia with posaconazole in a lung transplant recipient. J. Heart Lung Transplant. 23:1451-1454.
49. Howden, B. P., M. A. Slavin, A. P. Schwarer, and A. M. Mijch. 2003. Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine. Eur. J. Clin. Microbiol. Infect. Dis. 22:111-113.
50. Hue, F. X., M. Huerre, M. A. Rouffault, and C. de Bievre. 1999. Specific detection of Fusarium species in blood and tissues by a PCR technique. J. Clin. Microbiol. 37:2434-2438.
51. Jakle, C., J. C. Leek, D. A. Olson, and D. L. Robbins. 1983. Septic arthritis due to Fusarium solani. J. Rheumatol. 10:151-153.
52. Kerr, C. M., J. R. Perfect, P. C. Craven, J. H. Jorgensen, D. J. Drutz, J. D. Shelburne, H. A. Gallis, and R. A. Gutman. 1983. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann. Intern. Med. 99:334-336.
53. Kiehn, T. E., P. E. Nelson, E. M. Bernard, F. F. Edwards, B. Koziner, and D. Armstrong. 1985. Catheter-associated fungemia caused by Fusarium chlamydosporum in a patient with lymphocytic lymphoma. J. Clin. Microbiol. 21:501-504.
54. Kivivuori, S. M., L. Hovi, K. Vettenranta, and U. M. Saarinen-Pihkala. 2004. Invasive fusariosis in two transplanted children. Eur. J. Pediatr. 163: 692-693.
55. Kratka, J., and E. Kovacikova. 1979. The effect of temperature and age of strains of Fusarium oxysporum on its enzymatic activity. Zentbl. Bakteriol. Naturwiss. 134:154-158.
56. Kurien, M., V. Anandi, R. Raman, and K. N. Brahmadathan. 1992. Maxillary sinus fusariosis in immunocompetent hosts. J. Laryngol. Otol. 106: 733-736.
57. Legrand, C., E. Anaissie, R. Hashem, P. Nelson, G. P. Bodey, and J. Ro. 1991. Experimental fusarial hyalohyphomycosis in a murine model. J. Infect. Dis. 164:944-948.
58. Letscher-Bru, V., F. Campos, J. Waller, R. Randriamahazaka, E. Candolfi, and R. Herbrecht. 2002. Successful outcome of treatment of a disseminated infection due to Fusarium dimerum in a leukemia patient. J. Clin. Microbiol. 40:1100-1102.
59. Liu, K., D. N. Howell, J. R. Perfect, and W. A. Schell. 1998. Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology. Am. J. Clin. Pathol. 109:45-54.
60. Lopes, J. O., E. S. de Mello, and C. Klock. 1995. Mixed intranasal infection caused by Fusarium solani and a zygomycete in a leukaemic patient. Mycoses 38:281-284.
61. Lupinetti, F. M., R. H. Giller, and M. E. Trigg. 1990. Operative treatment of Fusarium fungal infection of the lung. Ann. Thorac. Surg. 49:991-992.
62. Madhavan, M., C. Ratnakar, A. J. Veliath, R. Kanungo, S. R. Smile, and S. Bhat. 1992. Primary disseminated fusarial infection. Postgrad. Med. J. 68: 143-144.
63. Mahfouz, T., M. H. Miceli, F. Saghafifar, S. Stroud, L. Jones-Jackson, R. Walker, M. L. Grazziutti, G. Purnell, A. Fassas, G. Tricot, B. Barlogie, and E. Anaissie. 2005. 18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: a study of 165 infectious episodes. J. Clin. Oncol. 23: 7857-7863.
64. Makowsky, M. J., D. I. Warkentin, and M. L. Savoie. 2005. Caspofungin and amphotericin B for disseminated Fusarium verticillioides in leukemia. Ann. Pharmacother. 39:1365-1366.
65. Mansoory, D., N. A. Roozbahany, H. Mazinany, and A. Samimagam. 2003. Chronic Fusarium infection in an adult patient with undiagnosed chronic granulomatous disease. Clin. Infect. Dis. 37:e107-e108.
66. Mayayo, E., I. Pujol, and J. Guarro. 1999. Experimental pathogenicity of four opportunist Fusarium species in a murine model. J. Med. Microbiol. 48:363-366.
67. Meletiadis, J., J. F. Meis, J. W. Mouton, J. P. Donnelly, and P. E. Verweij. 2000. Comparison of NCCLS and 3-(4,5-dimethyl-2-thiazyl)-2,5- diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method. J. Clin. Microbiol. 38:2949-2954.
68. Moschovi, M., G. Trimis, J. Anastasopoulos, M. Kanariou, A. Raftopoulou, and F. Tzortzatou-Stathopoulou. 2004. Subacute vertebral osteomyelitis in a child with diabetes mellitus associated with Fusarium. Pediatr. Int. 46: 740-742.
69. Murray, C. K., M. L. Beckius, and K. McAllister. 2003. Fusarium proliferatum superficial suppurative thrombophlebitis. Mil. Med. 168:426-427.
70. Musa, M. O., A. Al Eisa, M. Halim, E. Sahovic, M. Gyger, N. Chaudhri, F. Al Mohareb, P. Seth, M. Aslam, and M. Aljurf. 2000. The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non-immunocompromised patients: a single institution experience over 10 years. Br. J. Haematol. 108:544-548.
71. Nakar, C., G. Livny, I. Levy, Z. Samra, N. Linder, S. Ashkenazi, P. Livne, and L. Sirota. 2001. Mycetoma of the renal pelvis caused by Fusarium species. Pediatr. Infect. Dis. J. 20:1182-1183.
72. Nelson, P. E., M. C. Dignani, and E. J. Anaissie. 1994. Taxonomy, biology, and clinical aspects of Fusarium species. Clin. Microbiol. Rev. 7:479-504.
73. Ninet, B., I. Jan, O. Bontems, B. Lechenne, O. Jousson, D. Lew, J. Schrenzel, R. G. Panizzon, and M. Monod. 2005. Molecular identification of Fusarium species in onychomycoses. Dermatology 210:21-25.
74. Nucci, M., and E. Anaissie. 2002. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin. Infect. Dis. 35:909-920.
75. Nucci, M., E. J. Anaissie, F. Queiroz-Telles, C. A. Martins, P. Trabasso, C. Solza, C. Mangini, B. P. Simoes, A. L. Colombo, J. Vaz, C. E. Levy, S. Costa, V. A. Moreira, J. S. Oliveira, N. Paraguay, G. Duboc, J. C. Voltarelli, A. Maiolino, R. Pasquini, and C. A. Souza. 2003. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 98:315-319.
76. Nucci, M., K. A. Marr, F. Queiroz-Telles, C. A. Martins, P. Trabasso, S. Costa, J. C. Voltarelli, A. L. Colombo, A. Imhof, R. Pasquini, A. Maiolino, C. A. Souza, and E. Anaissie. 2004. Fusarium infection in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 38:1237-1242.
77. Odabasi, Z., G. Mattiuzzi, E. Estey, H. Kantarjian, F. Saeki, R. J. Ridge, P. A. Ketchum, M. A. Finkelman, J. H. Rex, and L. Ostrosky-Zeichner. 2004. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin. Infect. Dis. 39:199-205.
78. O'Donnell, K., D. A. Sutton, M. G. Rinaldi, K. C. Magnon, P. A. Cox, S. G. Revankar, S. Sanche, D. M. Geiser, J. H. Juba, J. A. van Burik, A. Padhye, E. J. Anaissie, A. Francesconi, T. J. Walsh, and J. S. Robinson. 2004. Genetic diversity of human pathogenic members of the Fusarium oxysporum complex inferred from multilocus DNA sequence data and amplified fragment length polymorphism analyses: evidence for the recent dispersion of a geographically widespread clonal lineage and nosocomial origin. J. Clin. Microbiol. 42:5109-5120.
79. Ortoneda, M., J. Guarro, M. P. Madrid, Z. Caracuel, M. I. Roncero, E. Mayayo, and P. A. Di. 2004. Fusarium oxysporum as a multihost model for the genetic dissection of fungal virulence in plants and mammals. Infect. Immun. 72:1760-1766.
80. Ostrosky-Zeichner, L., B. D. Alexander, D. H. Kett, J. Vazquez, P. G. Pappas, F. Saeki, P. A. Ketchum, J. Wingard, R. Schiff, H. Tamura, M. A. Finkelman, and J. H. Rex. 2005. Multicenter clinical evaluation of the (1→3)beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin. Infect. Dis. 41:654-659.
81. Paphitou, N. I., L. Ostrosky-Zeichner, V. L. Paetznick, J. R. Rodriguez, E. Chen, and J. H. Rex. 2002. In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results. Antimicrob. Agents Chemother. 46:3298-3300.
82. Pereiro, M., Jr., M. T. Abalde, A. Zulaica, J. L. Caeiro, A. Florez, C. Peteiro, and J. Toribio. 2001. Chronic infection due to Fusarium oxysporum mimicking lupus vulgaris: case report and review of cutaneous involvement in fusariosis. Acta Derm. Venereol. 81:51-53.
83. Perfect, J. R. 2005. Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex. Clin. Infect. Dis. 40(Suppl. 6):S401-S408.
84. Perfect, J. R., K. A. Marr, T. J. Walsh, R. N. Greenberg, B. DuPont, J. de la Torre-Cisneros, G. Just-Nubling, H. T. Schlamm, I. Lutsar, A. Espinel-Ingroff, and E. Johnson. 2003. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin. Infect. Dis. 36:1122-1131.
85. Pfaller, M. A., and D. J. Diekema. 2004. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J. Clin. Microbiol. 42:4419-4431.
86. Pflugfelder, S. C., H. W. Flynn, Jr., T. A. Zwickey, R. K. Forster, A. Tsiligianni, W. W. Culbertson, and S. Mandelbaum. 1988. Exogenous fungal endophthalmitis. Ophthalmology 95:19-30.
87. Pushker, N., M. Chra, M. S. Bajaj, S. Ghose, N. Naik, S. Kashyap, and G. Satpathy. 2002. Necrotizing periorbital Fusarium infection - an emerging pathogen in immunocompetent individuals. J. Infect. 44:236-239.
88. Raad, I., and R. Hachem. 1995. Treatment of central venous catheter-related fungemia due to Fusarium oxysporum. Clin. Infect. Dis. 20:709-711.
89. Raad, I., J. Tarrand, H. Hanna, M. Albitar, E. Janssen, M. Boktour, G. Bodey, M. Mardani, R. Hachem, D. Kontoyiannis, E. Whimbey, and K. Rolston. 2002. Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer. Infect. Control Hosp. Epidemiol. 23:532-537.
90. Raad, I. I., R. Y. Hachem, R. Herbrecht, J. R. Graybill, R. Hare, G. Corcoran, and D. P. Kontoyiannis. 2006. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin. Infect. Dis. 42:1398-1403.
91. Rezai, K. A., D. Eliott, O. Plous, J. A. Vazquez, and G. W. Abrams. 2005. Disseminated Fusarium infection presenting as bilateral endogenous endophthalmitis in a patient with acute myeloid leukemia. Arch. Ophthalmol. 123:702-703.
92. Rippon, J. W., R. A. Larson, D. M. Rosenthal, and J. Clayman. 1988. Disseminated cutaneous and peritoneal hyalohyphomycosis caused by Fusarium species: three cases and review of the literature. Mycopathologia 101:105-111.
93. Rodriguez, C. A., J. Lujan-Zilbermann, P. Woodard, M. Andreansky, and E. E. Adderson. 2003. Successful treatment of disseminated fusariosis. Bone Marrow Transplant. 31:411-412.
94. Romani, L. 2004. Immunity to fungal infections. Nat. Rev. Immunol. 4:1-23.
95. Rothe, A., M. Seibold, T. Hoppe, H. Seifert, A. Engert, C. Caspar, M. Karthaus, G. Fatkenheuer, U. Bethe, K. Tintelnot, and O. A. Cornely. 2004. Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B. Ann. Hematol. 83:394-397.
96. Sampathkumar, P., and C. V. Paya. 2001. Fusarium infection after solid-organ transplantation. Clin. Infect. Dis. 32:1237-1240.
97. Sander, A., U. Beyer, and R. Amberg. 1998. Systemic Fusarium oxysporum infection in an immunocompetent patient with an adult respiratory distress syndrome (ARDS) and extracorporal membrane oxygenation (ECMO). Mycoses 41:109-111.
98. Saw, S. M., P. L. Ooi, D. T. Tan, W. B. Khor, C. W. Fong, J. Lim, H. Y. Cajucom-Uy, D. Heng, S. K. Chew, T. Aung, A. L. Tan, C. L. Chan, S. Ting, P. A. Tambyah, and T. Y. Wong. 2007. Risk factors for contact lens-related fusarium keratitis: a case-control study in Singapore. Arch. Ophthalmol. 125:611-617.
99. Segal, B. H., T. J. Walsh, J. M. Liu, J. D. Wilson, and K. J. Kwon-Chung. 1998. Invasive infection with Fusarium chlamydosporum in a patient with aplastic anemia. J. Clin. Microbiol. 36:1772-1776.
100. Shoham, S., and S. M. Levitz. 2005. The immune response to fungal infections. Br. J. Haematol. 129:569-582.
101. Sierra-Hoffman, M., S. Paltiyevich-Gibson, J. L. Carpenter, and D. L. Hurley. 2005. Fusarium osteomyelitis: case report and review of the literature. Scand. J. Infect. Dis. 37:237-240.
102. Sridhar, H., J. R. Subramanyam, L. Appaji, M. Shafiulla, and B. R. Vijaykumar. 2001. Fusarium solani fungemia in a patient with acute lymphoblastic leukemia. Indian J. Cancer 38:19-21.
103. Stammberger, H. 1985. Endoscopic surgery for mycotic and chronic recurring sinusitis. Ann. Otol. Rhinol. Laryngol. Suppl. 119:1-11.
104. Sturm, A. W., W. Grave, and W. S. Kwee. 1989. Disseminated Fusarium oxysporum infection in patient with heatstroke. Lancet i:968.
105. Szekely, A., E. M. Johnson, and D. W. Warnock. 1999. Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds. J. Clin. Microbiol. 37:1480-1483.
106. Tiribelli, M., F. Zaja, C. Fili, T. Michelutti, S. Prosdocimo, A. Candoni, and R. Fanin. 2002. Endogenous endophthalmitis following disseminated fungemia due to Fusarium solani in a patient with acute myeloid leukemia. Eur. J. Haematol. 68:314-317.
107. Tomimori-Yamashita, J., M. M. Ogawa, S. H. Hirata, O. Fischman, N. S. Michalany, H. K. Yamashita, and M. Alchorne. 2002. Mycetoma caused by Fusarium solani with osteolytic lesions on the hand: case report. Mycopathologia 153:11-14.
108. Valenstein, P., and W. A. Schell. 1986. Primary intranasal Fusarium infection. Potential for confusion with rhinocerebral zygomycosis. Arch. Pathol. Lab. Med. 110:751-754.
109. Velasco, E., C. A. Martins, and M. Nucci. 1995. Successful treatment of catheter-related fusarial infection in immunocompromised children. Eur. J. Clin. Microbiol. Infect. Dis. 14:697-699.
110. Vincent, A. L., J. E. Cabrero, J. N. Greene, and R. L. Sandin. 2003. Successful voriconazole therapy of disseminated Fusarium solani in the brain of a neutropenic cancer patient. Cancer Control 10:414-419.
111. Wickern, G. M. 1993. Fusarium allergic fungal sinusitis. J. Allergy Clin. Immunol. 92:624-625.
112. Winn, R. M., C. Gil-Lamaignere, E. Roilides, M. Simitsopoulou, C. A. Lyman, A. Maloukou, and T. J. Walsh. 2005. Effects of interleukin-15 on antifungal responses of human polymorphonuclear leukocytes against Fusarium spp. and Scedosporium spp. Cytokine 31:1-8.
113. Yera, H., M. E. Bougnoux, C. Jeanrot, M. T. Baixench, P. G. De, and J. Dupouy-Camet. 2003. Mycetoma of the foot caused by Fusarium solani: identification of the etiologic agent by DNA sequencing. J. Clin. Microbiol. 41:1805-1808.